Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "Markets"

1302 News Found

Lupin completes acquisition of VISUfarma
News | April 02, 2026

Lupin completes acquisition of VISUfarma

The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe


Agilent opens new customer experience center in Mumbai
Technology | April 02, 2026

Agilent opens new customer experience center in Mumbai

The center brings together hands on technology demonstrations, application expertise, and commercial operations


VLCC becomes exclusive partner to offer international laser certification exams in India
News | April 01, 2026

VLCC becomes exclusive partner to offer international laser certification exams in India

This makes VLCC the sole institution in the country authorised to conduct in-person NCLC exams


Samsung Biologics scores big at 2026 CDMO Leadership Awards
News | March 31, 2026

Samsung Biologics scores big at 2026 CDMO Leadership Awards

The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers


Lupin receives FDA’s tentative approval for Sugammadex injection
Drug Approval | March 31, 2026

Lupin receives FDA’s tentative approval for Sugammadex injection

Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery


HRV Pharma and Shodhana Laboratories forge CDMO Alliance
News | March 31, 2026

HRV Pharma and Shodhana Laboratories forge CDMO Alliance

The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework


Shreehas Tambe appointed CEO & Managing Director of Biocon
People | March 28, 2026

Shreehas Tambe appointed CEO & Managing Director of Biocon

Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited


CuraTeQ Biologics enters into agreement with STADA Arzneimittel AG
News | March 27, 2026

CuraTeQ Biologics enters into agreement with STADA Arzneimittel AG

STADA will market and distribute two EMA approved biosimilars developed by CuraTeQ in select European Union territories


Japan okays new long-acting eye drug
News | March 24, 2026

Japan okays new long-acting eye drug

It promises fewer injections for vision loss patients